Advertisement
Research Article| Volume 78, ISSUE 2, P216-229, August 1971

Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients

  • Daniel J. McCarty
    Correspondence
    Reprint requests: Dr. Daniel J. McCarty, Dept. of Medicine, University of Chicago Pritzker School of Medicine, 950 E. 59th St., Chicago, Ill. 60637.
    Affiliations
    From the Section of Arthritis and Metabolism, Department of Medicine, University of Chicago Pritzker School of Medicine, 950 E. 59th St., Chicago, Ill. 60637 USA
    Search for articles by this author
  • Sheldon D. Solomon
    Affiliations
    From the Section of Arthritis and Metabolism, Department of Medicine, University of Chicago Pritzker School of Medicine, 950 E. 59th St., Chicago, Ill. 60637 USA
    Search for articles by this author
  • Martha L. Warnock
    Affiliations
    From the Section of Arthritis and Metabolism, Department of Medicine, University of Chicago Pritzker School of Medicine, 950 E. 59th St., Chicago, Ill. 60637 USA
    Search for articles by this author
  • Edward Paloyan
    Affiliations
    From the Section of Arthritis and Metabolism, Department of Medicine, University of Chicago Pritzker School of Medicine, 950 E. 59th St., Chicago, Ill. 60637 USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      A radioisotope dilution technique for measurement of inorganic pyrophosphate (PPi) in synovial fluid is described. Its precision based on duplicate measurements is ±4 μg per 100 ml. PPi levels in 20 of 23 joint fluids from patients with arthritis other than pseudogout clustered about a mean ± S.D. of 22 ± 6.3; 3 control fluids showed elevated values. Of 18 joint fluids from patients with calcium pyrophosphate crystal deposition disease (pseudogout), 15 showed inorganic PPi levels that were greater than 2 S.D. from the control mean, 2 were borderline, and one fell in the normal range. The mean ± S.D. of the group was 100.4 ± 93. Inorganic orthophosphate, total and ionized calcium, alkaline phosphomonoesterase activity against both p-nitrophenylphosphate and β-glycerophosphate, and alkaline phosphomonoesterase isozymes were not significantly different in joint fluids from control and pseudogout patients. Preliminary studies on the solubility of calcium pyrophosphate dihydrate miscocrystals in various solvents such as distilled water, Tris buffer, dialyzed and anaerobically processed fresh joint fluid and plasma are presented. The levels of PPi attained were of the same order of magnitude as those found in joint fluids from pseudogout patients. Magnesium ions and protein increased solubility; calcium and orthophosphate ions decreased it. Whether or not the PPi levels found in pseudogout fluid represent saturation levels in vivo cannot be answered from the present data.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McCarty DJ
        • Kohn NN
        • Faires JS
        The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome.” I. Clinical aspects.
        Ann Intern Med. 1962; 56: 711-737
        • Žitňan D
        • Siťaj S
        Articular chondrocalcinosis.
        Ann Rheum Dis. 1963; 22: 142
        • McCarty DJ
        • Hogan JM
        • Gatter RA
        • et al.
        Studies on pathological calcifications in human cartilage.
        J Bone Joint Surg. 1966; 48A: 309-326
        • McCarty DJ
        • Haskin M
        The roentgenographic aspects of pseudogout (articular chondrocalcinosis); an analysis of 20 cases.
        Am J Roentgenol. 1963; 90: 1248-1257
        • Pflug M
        • McCarty DJ
        • Kawahara F
        Basal urinary pyrophosphate excretion in pseudogout.
        Arthritis Rheum. 1969; 12: 228-231
        • Russell RGG
        • Bisaz S
        • Fleisch H
        • et al.
        Inorganic pyrophosphate in the plasma, urine and synovial fluid of patients with pyrophosphate arthropathy, chondrocalcinosis or pseudogout.
        Lancet. 1970; 2: 899-902
        • Parlee DE
        • Freundlich IM
        • McCarty DJ
        A comparative study of roentgenographic techniques for detection of calcium pyrophosphate dihydrate deposits (pseudogout) in human cartilage.
        Am J Roentgenol. 1967; 99: 688-694
        • Phelps P
        • Steele AD
        • McCarty DJ
        Compensated polarized light microscopy.
        JAMA. 1968; 203: 508-512
      1. Thomas WC, and Lewis AM: Inorganic pyrophosphate in serum and urine. Submitted for publication.

        • Fiske CH
        • SubbaRow Y
        The colorimetric determination of phosphorus.
        J Biol Chem. 1925; 66: 375-400
        • Chen PS
        • Toribara TY
        • Warner H
        Microdetermination of phosphorus.
        Anal Chem. 1956; 28: 1756-1758
        • Kingsley GR
        • Robnett O
        New dye method for direct photometric determination of calcium.
        Am J Clin Pathol. 1957; 27: 223-230
        • Moore EW
        • Blum AL
        Studies with ion-exchange calcium electrodes: the distribution of ionized calcium between blood and cerebrospinal fluid in man and dog.
        J Clin Invest. 1968; 47 (Abst.): 70
        • Willis JB
        The determination of metals in blood serum by atomic absorption spectroscopy I.
        Spectrochem Acta. 1960; 16: 259-272
        • Warnock M
        Characterization of tissue and serum alkaline phosphatase.
        Clin Chim Acta. 1966; 14: 156-165
        • Lowry OH
        • Rosebrough NJ
        • Farr AL
        • et al.
        Protein measurement with the Folin reagent.
        J Biol Chem. 1951; 193: 265
      2. Sörensen LB: Personal communication.

        • O'Duffy JD
        Hypophosphatasia associated with calcium pyrophosphate dihydrate deposits in cartilage.
        Arthritis Rheum. 1970; 13: 381-388
        • Cox RP
        • Griffin MJ
        Pyrophosphatase activity of mammalian alkaline phosphatase.
        Lancet. 1965; 2: 1018
        • Cox RP
        • Gilbert P
        • Griffin MJ
        Alkaline inorganic pyrophosphatase activity of mammalian-cell alkaline phosphatase.
        Biochem J. 1967; 105: 155
        • Eaton RH
        • Moss DW
        Alkaline orthophosphatase and inorganic pyrophosphatase activities in human serum.
        Nature. 1967; 214: 842-843
        • Yaron M
        • Zurkowsky P
        • Weiser HI
        • et al.
        Pseudogout with low values of alkaline phosphatase in the synovial fluid.
        Ann Intern Med. 1970; 73: 751-756
        • Good AE
        • Starkweather WH
        Synovial fluid pyrophosphate phosphohydrolase (PPPH) in pseudogout, gout, and rheumatoid arthritis.
        Arthritis Rheum. 1969; 12 (Abst.): 298
        • McCarty DJ
        • Pepe PF
        • Solomon SD
        • et al.
        Inhibition of human erythrocyte pyrophosphatase activity by calcium, cupric and ferrous ions.
        Arthritis Rheum. 1970; 13 (Abst.): 354
        • Valsik J
        • Žitn̆an D
        • Siťaj S
        Chondrocalcinosis articularis. II. Genetic study.
        Ann Rheum Dis. 1963; 22: 142-151
        • Reginato A
        • Valenzuela FR
        • Martinéz VC
        • et al.
        Polyarticular and familial chondrocalcinosis.
        Arthritis Rheum. 1970; 13: 197-213
        • Moskowitz RW
        • Katz D
        Chondrocalcinosis (pseudogout syndrome). A family study.
        JAMA. 1964; 188: 867-871
        • McCarty DJ
        Calcium pyrophosphate crystal deposition disease (pseudogout, articular chondrocalcinosis).
        in: Hollander JL Arthritis and allied conditions. Lea & Febiger, Philadelphia1965: 113-118
        • de Seze S
        • Hubault A
        • Welfling J
        • et al.
        Les arthropathies des hemochromatoses.
        Rev Rhumatisme Malad Osteoartic. 1964; 31: 479-485
        • Hamilton E
        • Williams R
        • Barlow KA
        • et al.
        The arthropathy of idiopathic haemochromatosis.
        Quart J Med. 1968; 37: 171-182
        • McCarty DJ
        • Gatter RA
        Pseudogout syndrome (articular chondrocalcinosis).
        Bull Rheum Dis. 1964; 14: 331-334